Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension

NCT07784296 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2026-08-25

No results posted yet for this study

Summary

A multicenter, prospective, non-interventional, observational study to evaluate effectiveness and safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone) in Korean patients with hypertension

Conditions

Interventions

DRUG

AMOPREL TAB 1.67/16.67/4.17mg

Follow-up of subjects prescribed medication in a non-intervention study

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-19
Primary Completion
2028-08-31
Completion
2028-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07784296 on ClinicalTrials.gov